Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Statin Combined With PD-1/PD-L1 Inhibitors in Treating NSCLC

NCT05636592 is registered in ClinicalTrials.gov with The Fourth Affiliated Hospital of Zhejiang University School of Medicine as lead sponsor.

NCT NCT05636592
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05636592 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Statin Combined With PD-1/PD-L1 Inhibitors in Treating NSCLC
Lead sponsor
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Phase
Observational
Overall status
Active, not recruiting
Start date
October 15, 2022
Completion date
December 31, 2027
Enrollment
250 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer